MetaCap

Exelixis Statistics

NASDAQ: EXELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

64.63-1.20 (-1.82%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Exelixis by the numbers

Exelixis has a market capitalization of $15.77 billion based on 244.01M shares outstanding. Its trailing P/E ratio is 19.4, below the 5-company peer median of 26.6, and its forward P/E is 15.1. The stock trades 2.3% above its 50-day average and 22.3% above its 200-day average.

Average daily trading volume is 2.45M shares, or about $158.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

EXEL valuation vs. peer median

EXEL compared with the median of 8 peer companies
MetricEXELPeer medianDifference
Market cap$15.77B$10.44B+51%
P/E (TTM)19.426.6-27%
Forward P/E15.125.0-39%
Avg. volume2.45M1.25M+95%

Peer median across 8 companies: NBIX, BNTX, TECH, RGEN, HALO, QGEN, KYMR, KRYS.

Valuation

Market cap
$15.77B
Price / sales (latest FY)
6.80

Price and trading

Previous close
65.83
Open
65.90
Day range
64.45 – 66.94
52-week range
39.71 – 73.69
52-week change
+52.03%
Beta
—
Volume
2.19M

Dividends and events

Annual dividend
None
Next earnings date
Oct 29, 2026

Additional statistics

Market Cap
15.77B
Pe
19.35
Forward Pe
15.12
Eps
3.34
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
73.69
Week52 Low
39.71
Avg Volume
2.45M
Shares Outstanding
244.01M
Ma50
63.20
Ma200
52.86
Earnings Date
Oct 29, 2026
Pct From52w High
-12.29%
Pct From52w Low
62.75%

Related